RENBIO

Serial Number 90981087
Registration 7477492
700

Registration Progress

Application Filed
Nov 10, 2020
Under Examination
Jan 4, 2022
Approved for Publication
Nov 9, 2021
Published for Opposition
Registered
Aug 20, 2024

Trademark Image

RENBIO

Basic Information

Serial Number
90981087
Registration Number
7477492
Filing Date
November 10, 2020
Registration Date
August 20, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Aug 20, 2024
Registration
Registered
Classes
042

Rights Holder

RENBIO, INC.

03
Address
30-02 48TH AVENUE
LONG ISLAND CITY, NY 11101

Ownership History

RenBio, Inc.

Original Applicant
03
Long Island City, NY

RenBio, Inc.

Owner at Publication
03
Long Island City, NY

RENBIO, INC.

New Owner After Publication #1
03
LONG ISLAND CITY, NY

RENBIO, INC.

Original Registrant
03
LONG ISLAND CITY, NY

Legal Representation

Attorney
Rachelle A. Dubow, Esq.

USPTO Deadlines

Next Deadline
1848 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-08-20)
Due Date
August 20, 2030
Grace Period Ends
February 20, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

42 events
Date Code Type Description Documents
Aug 20, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Aug 20, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jun 28, 2024 DP1B I 1(B) BASIS DELETED; PROCEED TO REGISTRATION Loading...
Jun 28, 2024 DPCC D DIVISIONAL PROCESSING COMPLETE Loading...
Jun 28, 2024 IUCN S NOTICE OF ALLOWANCE CANCELLED Loading...
Jun 28, 2024 DRRR I DIVISIONAL REQUEST RECEIVED Loading...
Jun 27, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jun 20, 2024 ERTD I TEAS REQUEST TO DIVIDE RECEIVED Loading...
Dec 12, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 8, 2023 EX4G S SOU EXTENSION 4 GRANTED Loading...
Dec 8, 2023 EXT4 S SOU EXTENSION 4 FILED Loading...
Dec 8, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 22, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 20, 2023 EXT3 S SOU EXTENSION 3 FILED Loading...
Jun 20, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 20, 2023 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jan 5, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 3, 2023 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jan 3, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 3, 2023 EXT2 S SOU EXTENSION 2 FILED Loading...
Jul 5, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 1, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 1, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jul 1, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
May 19, 2022 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Jan 4, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 9, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 9, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 20, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 7, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 6, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 5, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 5, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 9, 2021 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Sep 9, 2021 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Sep 9, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 5, 2021 GNRT F NON-FINAL ACTION E-MAILED Loading...
Apr 5, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 5, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 2, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 8, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 13, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Medical and scientific research in the field of drug delivery devices; Research and development in the pharmaceutical and biotechnology fields; Research and development of vaccines and medicines
First Use Anywhere: 20160000
First Use in Commerce: 20160000

Classification

International Classes
042